GSK agrees £1.6 billion acquisition of cough drug specialist
- All-cash acquisition of BELLUS Health at 103% premium- Deal expected to be earnings accretive from 2027- Potential blockbuster sales opportunity Pharma company GSK (GSK) has agreed to buy Canadian cough drug company BELLUS Health...
18 April 2023